<?xml version="1.0" encoding="UTF-8"?>
<p>GS-327073, 5-[{3-(4-chlorophenyl)-5-isoxazolyl} methyl]-2-(2, 3-difluorophenyl)-5H-imidazo [4,5-c] pyridine is proved to be highly effective against HCV replication by assessing in various HCV subgenomic replicons (genotypes 1b, 1a and 2a), in JFH-1 infectious system and against replicons which are sustained to be resistant for various HCV inhibitors. GS-327073, revealing pharmacokinetic characteristics 
 <italic>in-vitro </italic>has maintained anti-HCV activity for resistant replicons [
 <xref ref-type="bibr" rid="B45">45</xref>].
</p>
